Literature DB >> 16566291

Mouse models of inflammatory bowel disease.

Fergus R Byrne1, Joanne L Viney.   

Abstract

The past decade has seen an abundance of new mouse models that mimic the human inflammatory bowel diseases (IBDs), Crohn's disease and ulcerative colitis. These mouse models of IBD have provided great insight into the potential mechanisms that drive homeostatic dysregulation in the intestine, which manifests as mucosal inflammation. Within this review, the different animal models that have been employed to gain a greater understanding of the pathogenesis of IBD are discussed and some of the new biological drugs that have emerged as potential therapeutics as a result of these mouse modeling studies are reviewed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16566291

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  14 in total

1.  Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2-/- mice.

Authors:  Fang Zhao; Robert Edwards; Diana Dizon; Kambiz Afrasiabi; Jennifer R Mastroianni; Mikhail Geyfman; André J Ouellette; Bogi Andersen; Steven M Lipkin
Journal:  Dev Biol       Date:  2009-12-16       Impact factor: 3.582

2.  Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.

Authors:  R Ito; M Shin-Ya; T Kishida; A Urano; R Takada; J Sakagami; J Imanishi; M Kita; Y Ueda; Y Iwakura; K Kataoka; T Okanoue; O Mazda
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

3.  Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis.

Authors:  Lindsay J Hall; Emilie Faivre; Aoife Quinlan; Fergus Shanahan; Kenneth Nally; Silvia Melgar
Journal:  Dig Dis Sci       Date:  2010-05-14       Impact factor: 3.199

4.  IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis.

Authors:  Amy E Troy; Colby Zaph; Yurong Du; Betsy C Taylor; Katherine J Guild; Christopher A Hunter; Christiaan J M Saris; David Artis
Journal:  J Immunol       Date:  2009-07-13       Impact factor: 5.422

5.  A model for chronic mucosal inflammation in IBD and periodontitis.

Authors:  Helieh S Oz; Theresa Chen; Jeffrey L Ebersole
Journal:  Dig Dis Sci       Date:  2009-11-10       Impact factor: 3.199

6.  Effects of Lactobacillus salivarius 433118 on intestinal inflammation, immunity status and in vitro colon function in two mouse models of inflammatory bowel disease.

Authors:  Linda M Feighery; Philip Smith; Liam O'Mahony; Padraic G Fallon; David J Brayden
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

7.  Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro.

Authors:  Linda M Feighery; Sean W Cochrane; Teresa Quinn; Alan W Baird; Daniel O'Toole; Sian-Eleri Owens; Diarmuid O'Donoghue; Randall J Mrsny; David J Brayden
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

8.  Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB.

Authors:  Christian Sina; Alexander Arlt; Philip Rosenstiel; Heiner Schäfer; Olga Gavrilova; Emilie Midtling; Marie-Luise Kruse; Susanne Sebens Müerköster; Rajiv Kumar; Ulrich R Fölsch; Stefan Schreiber
Journal:  Inflamm Bowel Dis       Date:  2010-02       Impact factor: 5.325

9.  A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora.

Authors:  R J Rigby; M R Hunt; B P Scull; J G Simmons; K E Speck; M A Helmrath; P K Lund
Journal:  Gut       Date:  2009-04-26       Impact factor: 23.059

10.  Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis.

Authors:  Chi Chen; Yatrik M Shah; Keiichirou Morimura; Kristopher W Krausz; Makoto Miyazaki; Terrilyn A Richardson; Edward T Morgan; James M Ntambi; Jeffrey R Idle; Frank J Gonzalez
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.